Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is -41.36%.
Reported quarterly profit margin; no daily interpolation. Q4 FY2025 (2026-03-31): 0.00%.
NET PROFIT MARGIN
-41.36%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-11717.14%
vs the sector median at left
Market Cap
$63.78M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-2871.11%
5Y Avg
-2144.71%
Market Cap
$63.02M
Net Profit Margin
-13.72%
TTM Avg
-20.80%
3Y Avg
-11.88%
5Y Avg
-17.10%
Market Cap
$62.78M
Net Profit Margin
-22.52%
TTM Avg
-11.22%
3Y Avg
-69.63%
5Y Avg
-131.75%
Market Cap
$62.62M
Net Profit Margin
-621.71%
TTM Avg
-10746.07%
3Y Avg
-5373.04%
5Y Avg
-3582.02%
Market Cap
$65.85M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-205.11%
5Y Avg
-156.77%
Market Cap
$65.87M
Net Profit Margin
-235.00%
TTM Avg
-200.38%
3Y Avg
-100.19%
5Y Avg
-66.80%
Market Cap
$67.52M
Net Profit Margin
-33044.00%
TTM Avg
-18819.13%
3Y Avg
-12177.01%
5Y Avg
-8726.92%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alps Group Inc (ALPS) | $64.18M | -41.36% | 0.00% | 0.00% | N/A |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | 0.00% | 0.00% | -2871.11% | -2144.71% |
| InterCure Ltd. (INCR)vs › | $63.02M | -13.72% | -20.80% | -11.88% | -17.10% |
| Heron Therapeutics, Inc. (HRTX)vs › | $62.78M | -22.52% | -11.22% | -69.63% | -131.75% |
| RenovoRx, Inc. (RNXT)vs › | $62.62M | -621.71% | -10746.07% | -5373.04% | -3582.02% |
| XBiotech Inc. (XBIT)vs › | $65.85M | 0.00% | 0.00% | -205.11% | -156.77% |
| Cingulate Inc. (CING)vs › | $65.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.87M | -235.00% | -200.38% | -100.19% | -66.80% |
| iBio, Inc. (IBIO)vs › | $67.52M | -33044.00% | -18819.13% | -12177.01% | -8726.92% |
| Fractyl Health, Inc. (GUTS)vs › | $60.42M | 0.00% | -36932.26% | -34526.76% | -23017.84% |
Operating Margin
-69.6%
Net Profit Margin
-41.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-03-31 | 1.41% |
| 2022-12-31 | -3.02% |
